Fredun Pharmaceuticals Limited (BOM:539730)
India · Delayed Price · Currency is INR 1,472.90
-31.95 (-2.12%)
At close: Jan 21, 2026
Fredun Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 275.34 | 197.39 | 156.23 | 108.07 | 63.35 | 20.15 | Upgrade |
Depreciation & Amortization | 61.16 | 49.14 | 37.42 | 27.65 | 21.33 | 19.82 | Upgrade |
Other Amortization | 1.26 | 1.26 | 0.54 | 0.44 | 0.24 | 0.22 | Upgrade |
Other Operating Activities | 357.61 | 303.08 | 187.99 | 155.43 | 79 | 66.47 | Upgrade |
Change in Accounts Receivable | 59.89 | -1,123 | -302.89 | 557.13 | -491.98 | -21.01 | Upgrade |
Change in Inventory | -982.53 | -648.91 | -248.74 | -1,037 | 211.14 | -171.13 | Upgrade |
Change in Accounts Payable | 1,397 | 818.41 | 36.04 | 107.26 | -113.44 | 137.37 | Upgrade |
Change in Income Taxes | 11.41 | 15.81 | 12.45 | -27.91 | -5.45 | -21.99 | Upgrade |
Change in Other Net Operating Assets | -821.21 | 95.92 | 116.57 | -35.53 | 212 | -28.2 | Upgrade |
Operating Cash Flow | 360.21 | -290.63 | -4.39 | -144.09 | -23.8 | 1.7 | Upgrade |
Capital Expenditures | -187.9 | -61.06 | -76.39 | -94.95 | -42.86 | -13.88 | Upgrade |
Sale of Property, Plant & Equipment | 1.12 | 1.12 | - | 0.9 | 1.43 | - | Upgrade |
Investment in Securities | -3.6 | -3.6 | - | - | - | - | Upgrade |
Investing Cash Flow | -190.38 | -63.54 | -76.39 | -94.05 | -41.43 | -13.88 | Upgrade |
Short-Term Debt Issued | - | 640.82 | 216.05 | 271.78 | 1.97 | - | Upgrade |
Long-Term Debt Issued | - | - | - | 68.89 | 129.29 | 176.15 | Upgrade |
Total Debt Issued | 231.55 | 640.82 | 216.05 | 340.67 | 131.25 | 176.15 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | - | -128.71 | Upgrade |
Long-Term Debt Repaid | - | -24.45 | -26.42 | - | - | - | Upgrade |
Total Debt Repaid | 1.75 | -24.45 | -26.42 | - | - | -128.71 | Upgrade |
Net Debt Issued (Repaid) | 233.3 | 616.37 | 189.63 | 340.67 | 131.25 | 47.44 | Upgrade |
Issuance of Common Stock | - | 0.33 | - | - | - | - | Upgrade |
Other Financing Activities | -276.16 | -225.53 | -129.7 | -88.9 | -56.58 | -54.57 | Upgrade |
Financing Cash Flow | -42.91 | 391.16 | 59.93 | 251.77 | 74.67 | -7.13 | Upgrade |
Miscellaneous Cash Flow Adjustments | 0 | 0 | -0 | -0 | - | 0 | Upgrade |
Net Cash Flow | 126.93 | 36.99 | -20.85 | 13.63 | 9.44 | -19.31 | Upgrade |
Free Cash Flow | 172.32 | -351.69 | -80.78 | -239.03 | -66.66 | -12.18 | Upgrade |
Free Cash Flow Margin | 3.25% | -7.75% | -2.32% | -8.70% | -2.97% | -0.91% | Upgrade |
Free Cash Flow Per Share | 37.12 | -75.76 | -17.40 | -53.38 | -16.05 | -3.05 | Upgrade |
Cash Interest Paid | 274.15 | 223.77 | 136.5 | 92.82 | 46.69 | 41.62 | Upgrade |
Levered Free Cash Flow | -204.59 | -551.15 | -269.38 | -445.24 | -337.49 | -79.01 | Upgrade |
Unlevered Free Cash Flow | -45.45 | -423.5 | -191.14 | -397.98 | -310.05 | -55.02 | Upgrade |
Change in Working Capital | -335.14 | -841.49 | -386.57 | -435.68 | -187.73 | -104.95 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.